Cowen and Company’s Innoviva INVA Stock Holding History

Cowen and Company’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-59,258	Closed	-$619K	–	464
2020 Q3	$619K	Buy	+59,258	New	+$753K	0.1%	124

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cowen and Company's INVA Position: Q4 2020 in Review

Cowen and Company sold out of Innoviva (INVA) in Q4 2020, closing a stake of 59,258 shares — an estimated $619K sold.

Cowen and Company first reported a position in INVA in Q3 2020 and held it in 1 quarter. The position peaked at $619K in Q3 2020. 194 funds tracked by Wall St. Rank hold INVA as of Q4 2020.

Cowen and Company reported no remaining Innoviva position as of Q4 2020 after selling out during the quarter.
Cowen and Company sold 59,258 Innoviva shares in Q4 2020, an estimated $619K.
Cowen and Company first reported a position in Innoviva in Q3 2020 and held it in 1 quarter.
Cowen and Company's Innoviva position peaked at $619K in Q3 2020.
194 funds tracked by Wall St. Rank held Innoviva as of Q4 2020.

Based on Cowen and Company's 13F filing for Q4 2020, filed 8 Feb 2021.